Suppr超能文献

展示产气荚膜梭菌 NetB 抗原的干酪乳杆菌可保护鸡免受坏死性肠炎的侵害。

Lactobacillus casei displaying Clostridium perfringens NetB antigen protects chickens against necrotic enteritis.

机构信息

Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, 7616914111, Kerman, Iran.

出版信息

Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6441-6453. doi: 10.1007/s00253-022-12155-y. Epub 2022 Sep 5.

Abstract

Necrotic enteritis is a serious economical disease of poultry caused by Clostridium perfringens. NetB toxin of Clostridium perfringens is considered the causative agent of necrotic enteritis. Following the withdrawal of in-feed antibiotic growth promoters, there has been an urgent need to develop alternative approaches such as vaccination. Currently, there are no commercially available vaccines to control necrotic enteritis especially in broiler chickens as the target population. In the present study, we constructed a recombinant Lactobacillus casei strain expressing NetB protein of C. perfringens on the cell surface and used this probiotic-based vaccine strain to immunize broiler chickens orally against experimental induction of necrotic enteritis. The birds immunized with the oral vaccine strain were significantly protected against necrotic enteritis challenge and developed strong serum anti-NetB antibody responses to NetB protein. Furthermore, the immunized birds showed higher body weight gains during the challenge experiment compared with control birds. This study showed, for the first time, that a probiotic-based vector vaccine could be a promising vaccine candidate to provide protection against necrotic enteritis in broiler chickens. KEYPOINTS: • The probiotic L. casei carrying pT1NX-netB plasmid displayed NetB antigen on the cell surface. • The LC-NetB vaccine strain induced high anti-toxin antibody response in broiler chickens. • The LC-NetB vector vaccine provided significant protection against experimental NE challenge.

摘要

坏死性肠炎是一种由产气荚膜梭菌引起的严重经济禽类疾病。产气荚膜梭菌的 NetB 毒素被认为是坏死性肠炎的病原体。在停止使用饲料中添加的抗生素生长促进剂后,人们迫切需要开发替代方法,如接种疫苗。目前,尚无市售疫苗可用于控制坏死性肠炎,特别是针对肉鸡这一目标群体。在本研究中,我们构建了一种重组干酪乳杆菌菌株,该菌株在细胞表面表达产气荚膜梭菌的 NetB 蛋白,并使用这种基于益生菌的疫苗菌株通过口服免疫肉鸡,以预防实验诱导的坏死性肠炎。与对照组相比,用口服疫苗株免疫的鸡受到显著保护,免受坏死性肠炎的挑战,并对 NetB 蛋白产生强烈的血清抗 NetB 抗体反应。此外,与对照组相比,免疫组的鸡在挑战实验期间的体重增加更高。这项研究首次表明,基于益生菌的载体疫苗可能是预防肉鸡坏死性肠炎的一种有前途的疫苗候选物。关键点: • 携带 pT1NX-netB 质粒的益生菌 L. casei 在细胞表面展示了 NetB 抗原。 • LC-NetB 疫苗株在肉鸡中诱导了高抗毒素抗体反应。 • LC-NetB 载体疫苗对实验性 NE 挑战提供了显著的保护。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验